TY - JOUR
T1 - A role for L-glutamate ionotropic receptors in the development of rat neurogenic pulmonary edema
AU - Kondo, Hiroko
AU - Feng, Guo Gang
AU - Nishiwaki, Kimitoshi
AU - Shimada, Yasuhiro
AU - Hirokawa, Mitsuru
AU - Komatsu, Toru
AU - Yokochi, Takashi
AU - Ishikawa, Naohisa
PY - 2004/9/24
Y1 - 2004/9/24
N2 - The present study was undertaken to evaluate possible roles of l-glutamate ionotropic receptors in neurogenic pulmonary edema. Perfusion of l-glutamate into the fourth ventricles of rats increased nitric oxide (NO) signals in the efflux solution concentration-dependently, significantly reducing both the occurrence and severity of neurogenic pulmonary edema. This effect was completely reversed by prior intracisternal injection of an NO synthase inhibitor, N ω-nitro-l-arginine methyl ester (l-NAME), or an N-methyl-d-aspartate (NMDA) receptor antagonist, dizocilpine maleate (MK-801), and partially by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a 2-amino-3-hydroxy-5-methyl-4-isoxazol propionic acid (AMPA)/kainic acid receptor antagonist. Administration of MK-801 or CNQX alone, without l-glutamate, almost completely prevented neurogenic pulmonary edema development. These results suggest that endogenous l-glutamate may facilitate underlining disease process, whereas l-glutamate exogenously applied into the fourth ventricle may have an inhibitory action via release of NO, through ionotropic receptors.
AB - The present study was undertaken to evaluate possible roles of l-glutamate ionotropic receptors in neurogenic pulmonary edema. Perfusion of l-glutamate into the fourth ventricles of rats increased nitric oxide (NO) signals in the efflux solution concentration-dependently, significantly reducing both the occurrence and severity of neurogenic pulmonary edema. This effect was completely reversed by prior intracisternal injection of an NO synthase inhibitor, N ω-nitro-l-arginine methyl ester (l-NAME), or an N-methyl-d-aspartate (NMDA) receptor antagonist, dizocilpine maleate (MK-801), and partially by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a 2-amino-3-hydroxy-5-methyl-4-isoxazol propionic acid (AMPA)/kainic acid receptor antagonist. Administration of MK-801 or CNQX alone, without l-glutamate, almost completely prevented neurogenic pulmonary edema development. These results suggest that endogenous l-glutamate may facilitate underlining disease process, whereas l-glutamate exogenously applied into the fourth ventricle may have an inhibitory action via release of NO, through ionotropic receptors.
KW - CNQX
KW - Ionotropic receptor
KW - l-glutamate
KW - MK-801
KW - Neurogenic pulmonary edema
KW - Nitric oxide
UR - https://www.scopus.com/pages/publications/4544354968
UR - https://www.scopus.com/inward/citedby.url?scp=4544354968&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2004.07.111
DO - 10.1016/j.ejphar.2004.07.111
M3 - Article
C2 - 15381047
AN - SCOPUS:4544354968
SN - 0014-2999
VL - 499
SP - 257
EP - 263
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3
ER -